Literature DB >> 6555062

Selective in vitro toxicity of purothionin conjugated to the monoclonal antibody 225.28S to a human high-molecular-weight melanoma-associated antigen.

K Imai, T Nakanishi, T Noguchi, A Yachi, S Ferrone.   

Abstract

The toxic agent purothionin was conjugated to the monoclonal antibody 225.28S to a human high-molecular-weight melanoma-accociated antigen. The toxic conjugate displayed in vitro toxicity to cultured human Colo 38 melanoma cells as indicated by reduced uptake of 3H-thymidine following a 24-h incubation and loss of cell viability following a 7-day incubation. The effect is dose-dependent and is specific since addition of the toxic conjugate to a cultured Raji B lymphoid cells did not affect their 3H-thymidine uptake or their viability.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6555062     DOI: 10.1007/bf00199166

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  13 in total

1.  Cytotoxicity of purothionin-A on various animal cells.

Authors:  T Nakanishi; H Yoshizumi; S Tahara; A Hakura; K Toyoshima
Journal:  Gan       Date:  1979-06

2.  Characterization of monoclonal antibodies to human melanoma-associated antigens.

Authors:  K Imai; A K Ng; S Ferrone
Journal:  J Natl Cancer Inst       Date:  1981-03       Impact factor: 13.506

3.  Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry.

Authors:  S W Burchiel; J C Martin; K Imai; S Ferrone; N L Warner
Journal:  Cancer Res       Date:  1982-10       Impact factor: 12.701

4.  Structural properties and tissue distribution of the antigen recognized by the monoclonal antibody 653.40S to human melanoma cells.

Authors:  P G Natali; K Imai; B S Wilson; A Bigotti; R Cavaliere; M A Pellegrino; S Ferrone
Journal:  J Natl Cancer Inst       Date:  1981-09       Impact factor: 13.506

5.  Imaging of human melanoma xenografts in nude mice with a radiolabeled monoclonal antibody.

Authors:  T Ghose; S Ferrone; K Imai; S T Norvell; S J Luner; R H Martin; A H Blair
Journal:  J Natl Cancer Inst       Date:  1982-10       Impact factor: 13.506

6.  ANTIBODIES TO BRADYKININ AND ANGIOTENSIN: A USE OF CARBODIIMIDES IN IMMUNOLOGY.

Authors:  T L GOODFRIEND; L LEVINE; G D FASMAN
Journal:  Science       Date:  1964-06-12       Impact factor: 47.728

7.  Amino acid sequence of a purothionin homolog from barley flour.

Authors:  Y Ozaki; K Wada; T Hase; H Matsubara; T Nakanishi; H Yoshizumi
Journal:  J Biochem       Date:  1980-02       Impact factor: 3.387

8.  ADCC of cultured human melanoma cells: analysis with monoclonal antibodies to human melanoma-associated antigens.

Authors:  K Imai; A K Ng; M C Glassy; S Ferrone
Journal:  Scand J Immunol       Date:  1981-10       Impact factor: 3.487

9.  Antibody-directed cytotoxic agents: use of monoclonal antibody to direct the action of toxin A chains to colorectal carcinoma cells.

Authors:  D G Gilliland; Z Steplewski; R J Collier; K F Mitchell; T H Chang; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205

10.  Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies.

Authors:  B S Wilson; K Imai; P G Natali; S Ferrone
Journal:  Int J Cancer       Date:  1981-09-15       Impact factor: 7.396

View more
  3 in total

1.  A monoclonal antibody to the carbohydrate chain on human hepatocellular carcinoma-associated antigen which suppressed tumor growth in nude mice.

Authors:  Y Fukuda; K Imai; K Miura; M Matsui; T Nakanishi; H Nakazato; J Masukawa; T Higashide; Y Hinoda; T Noguchi
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

2.  Mab labelled liposomes as selective vehicles for drugs in H.I.V. infected cells.

Authors:  G Rombi; G Piu; S Piro; V Anedda
Journal:  Cytotechnology       Date:  1993-01       Impact factor: 2.058

3.  Regression of human melanoma xenografts in nude mice injected with methotrexate linked to monoclonal antibody 225.28 to human high molecular weight-melanoma associated antigen.

Authors:  T Ghose; S Ferrone; A H Blair; Y Kralovec; M Temponi; M Singh; M Mammen
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.